Despite some flaws, the recommendations contained in the April 15th EO meaningfully improve drug affordability and incentivize continued innovation in the pharmaceutical sector. It strikes the right balance that is lacking in the recent efforts to impose price controls and, if it eventually becomes policy, will improve outcomes for patients now and in the future.
Surveys confirm that most Americans recognize the value of prescription drugs. But the same surveys also show that Americans are worried that they will be unable to afford needed medicines.
These conflicting feelings exemplify the inherent tension when it comes to prescription drugs – how do we incentivize innovation to help patients who lack efficacious treatments while also promoting greater affordability for medicines today?
Too often, proposals get this balance between innovation and affordability wrong.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Deregulation Is The Pathway To Greater Pharmaceutical Innovation
Wayne H Winegarden
Despite some flaws, the recommendations contained in the April 15th EO meaningfully improve drug affordability and incentivize continued innovation in the pharmaceutical sector. It strikes the right balance that is lacking in the recent efforts to impose price controls and, if it eventually becomes policy, will improve outcomes for patients now and in the future.
Surveys confirm that most Americans recognize the value of prescription drugs. But the same surveys also show that Americans are worried that they will be unable to afford needed medicines.
These conflicting feelings exemplify the inherent tension when it comes to prescription drugs – how do we incentivize innovation to help patients who lack efficacious treatments while also promoting greater affordability for medicines today?
Too often, proposals get this balance between innovation and affordability wrong.
Read the entire op-ed here:
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.